About Sol-gel (SLGL)
Sol-Gel Technologies Ltd operates as a clinical stage pharmaceutical company. The Company identifies and develops topical dermatological drug products for the treatment of skin diseases. Sol-Gel Technologies markets its products worldwide.
- USD7.28
- USD7.46
- USD7.28
- USD16.50
- 3.10%
- 12M
- 428.00
- 21.78k
- 20M
- 3.34
- -18.80%
Stock News
4 hours ago
Dow Jones Futures: Tariffs In Focus After Trump Budget; Tesla Rival Uber Leads 5 Stocks In Buy Zones
Yahoo
5 hours ago
Happiness researcher shares his '90-second rule' to live a better, more fulfilled life—it helps when you're angry or upset
CNBC
5 hours ago
Retirees are flocking to these 10 U.S. states—No. 1 offers low taxes and sunny weather
CNBC
6 hours ago
Fast-casual restaurants lean on loyalty programs to offset consumer pullback
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
